Mission Creek Capital Partners Inc. Purchases 13,457 Shares of Tempus AI, Inc. $TEM

Mission Creek Capital Partners Inc. lifted its position in shares of Tempus AI, Inc. (NASDAQ:TEMFree Report) by 28.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,212 shares of the company’s stock after acquiring an additional 13,457 shares during the period. Mission Creek Capital Partners Inc.’s holdings in Tempus AI were worth $2,953,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. First Horizon Advisors Inc. lifted its position in shares of Tempus AI by 12.7% during the 1st quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company’s stock worth $89,000 after buying an additional 208 shares during the last quarter. Wells Fargo & Company MN lifted its stake in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after purchasing an additional 278 shares during the last quarter. Bartlett & CO. Wealth Management LLC grew its stake in shares of Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock worth $39,000 after buying an additional 400 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Tempus AI by 10.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,594 shares of the company’s stock worth $268,000 after buying an additional 515 shares in the last quarter. Finally, Cherry Tree Wealth Management LLC bought a new position in shares of Tempus AI in the 1st quarter valued at $31,000. Institutional investors own 24.22% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a report on Friday, August 8th. Bank of America raised their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a report on Wednesday, June 25th. BTIG Research raised their price target on shares of Tempus AI from $75.00 to $85.00 and gave the company a “buy” rating in a research note on Wednesday, August 20th. Needham & Company LLC reiterated a “buy” rating and issued a $70.00 price target on shares of Tempus AI in a research report on Friday, August 8th. Finally, Morgan Stanley raised their price objective on Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 12th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $67.64.

View Our Latest Report on Tempus AI

Insider Activity

In other news, CEO Eric P. Lefkofsky sold 250,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $70.07, for a total transaction of $17,517,500.00. Following the completion of the sale, the chief executive officer owned 9,357,283 shares in the company, valued at $655,664,819.81. This trade represents a 2.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Erik Phelps sold 51,317 shares of the company’s stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the completion of the transaction, the executive vice president owned 97,779 shares in the company, valued at approximately $7,094,844.24. The trade was a 34.42% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 776,451 shares of company stock worth $53,022,688. 26.27% of the stock is owned by insiders.

Tempus AI Trading Down 4.0%

NASDAQ:TEM opened at $73.23 on Thursday. The firm has a 50-day moving average price of $64.06 and a two-hundred day moving average price of $59.37. The firm has a market cap of $12.72 billion, a price-to-earnings ratio of -61.54 and a beta of 4.98. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $91.45. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54.

Tempus AI (NASDAQ:TEMGet Free Report) last announced its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. The firm had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business’s revenue was up 89.5% compared to the same quarter last year. During the same period last year, the firm posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. On average, equities analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

About Tempus AI

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Further Reading

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEMFree Report).

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.